Eyelash Growth Treatment in Illinois (Eyelash Hypotrichosis)
Illinois adult care by secure video visit, self pay option starting at $49, MD-only, insurance is not required.
Eyelash hypotrichosis refers to having inadequate or insufficient eyelashes. Many adults experience thinning or loss of eyelashes due to aging, medical treatments, certain skin conditions, or habitual behaviors. Bimatoprost ophthalmic solution 0.03%, marketed as Latisse, is the only FDA-approved prescription treatment for eyelash hypotrichosis and works by extending the growth (anagen) phase of the eyelash hair cycle, resulting in longer, thicker, and darker lashes over 8 to 16 weeks. Originally developed as a glaucoma medication, eyelash growth was identified as a consistent side effect of prostaglandin analog eye drops. A critical point that patients must understand is that bimatoprost may cause iris darkening (increased brown pigmentation) that is likely permanent, particularly in patients with hazel, green, or mixed-color eyes. Additionally, periorbital fat atrophy (hollowing around the eyes) is a recognized risk that may not fully reverse after discontinuation. TeleDirectMD uses a safety-first telehealth approach that screens for red flags including active eye infections, eye pain, vision changes, history of macular edema or uveitis, recent eye surgery, and eyelash loss from underlying conditions such as alopecia areata or thyroid disease before determining whether a bimatoprost prescription by video visit is appropriate. If the history supports straightforward eyelash hypotrichosis without red flags, guideline-based treatment with bimatoprost may be reasonable by video, while adults with active eye disease, suspicious eyelid lesions, or medically complex eyelash loss are directed to in-person ophthalmology or dermatology care. This page is for adults located in Illinois, including Chicago, Aurora, Naperville, Joliet, Rockford, Springfield, Elgin, Peoria, Champaign, Waukegan, and surrounding areas.
Quick navigation:
- Self pay option starting at $49
- MD-only care (no mid-levels)
- Insurance is not required
- Licensed telehealth care for patients located in Illinois at the time of the visit
Last reviewed on 2026-03-15 by Parth Bhavsar, MD
ICD-10 commonly used: H02.739 (final coding depends on clinical details)
Online MD-Only Eyelash Growth Care in Illinois
- Evaluation for eyelash hypotrichosis and underlying causes
- Red-flag screening for eye disease and systemic conditions
- FDA-approved bimatoprost (Latisse) prescription when appropriate
- Detailed application technique and safety counseling
Adults 18+ only. TeleDirectMD is not an emergency service. Go to urgent care or the ER now for sudden vision loss, severe eye pain, eye trauma, signs of eye infection with swelling and discharge, or severe allergic reaction. TeleDirectMD does not prescribe controlled substances.
Eyelash Growth Telehealth Eligibility Checklist for Illinois
You are likely eligible for a TeleDirectMD video visit if ALL of these are true:
✓ You Are Eligible If
- You are 18 years old or older
- You are physically located in Illinois at the time of the visit
- You have thin, sparse, or inadequate eyelashes and are interested in a prescription growth treatment
- You do not have an active eye infection, eye inflammation, or recent eye surgery
- You do not have a history of macular edema or uveitis
- You do not have unexplained eyelash loss that may suggest an underlying condition needing in-person evaluation
- Insurance is not required. A self pay option is available.
✗ You Are Not Eligible If
- You are under 18 years old
- You have active eye infection, eye inflammation, or severe eye redness
- You have eye pain or sudden vision changes
- You have had eye surgery within the past 3 months
- You have a history of macular edema, uveitis, or uncontrolled glaucoma
- You are pregnant or breastfeeding
- You have sudden or patchy eyelash loss suggesting alopecia areata, thyroid disease, or another systemic condition needing in-person evaluation
If you have red-flag symptoms, seek urgent in-person care or emergency care immediately. TeleDirectMD is not appropriate for complex or severe cases.
How Online Eyelash Growth Treatment Works in Illinois
Book your video visit
Insurance is not required. No referral needed. Many visits are available same day, depending on scheduling. Before your visit, note whether you wear contact lenses, any history of eye disease or eye surgery, current eye medications including glaucoma drops, whether you are pregnant or breastfeeding, and any allergies to medications.
See a Illinois licensed MD by video
We review your eyelash concerns, medical history, eye health history, current medications, and screen for red flags including active eye disease, recent surgery, and underlying causes of eyelash loss. Photo assessment may be used to evaluate your current eyelash status and guide treatment decisions.
Get a treatment plan and, if appropriate, a prescription
If bimatoprost is clinically appropriate, we send an e-prescription to common Illinois pharmacies such as CVS Pharmacy, Walgreens, Walmart Pharmacy, Jewel-Osco Pharmacy, Mariano's Pharmacy. You receive detailed application instructions, safety counseling about iris darkening and periorbital changes, and clear guidance on expected timeline and when to follow up.
Illinois Telehealth Regulations for Online Eyelash Growth Care
The Illinois Telehealth Act (Public Act 102-0104) establishes a comprehensive framework for telehealth services, allowing providers to deliver care through real-time audio-video and other telecommunications technologies. Illinois law mandates insurance coverage parity for telehealth and permits the establishment of a provider-patient relationship without a prior in-person visit.
Location matters: you must be physically in Illinois during the visit. Insurance is not required. TeleDirectMD does not prescribe controlled substances.
TeleDirectMD vs Other Care Options for Eyelash Growth in Illinois
Here is how TeleDirectMD compares to common settings for eyelash growth treatment in Illinois:
| Care option | Typical cost | Wait time | Provider type | Best for |
|---|---|---|---|---|
| TeleDirectMD | Self pay option starting at $49 | Same day, often within hours | Board-certified MD only (no mid-levels) | Straightforward eyelash hypotrichosis needing FDA-approved bimatoprost prescription with safety screening and application guidance |
| Dermatologist | $150 to $400+ (varies) | Weeks to months (varies) | Dermatologist MD or DO | Eyelash loss from skin conditions, alopecia areata, or other dermatologic causes needing in-person exam and biopsy |
| Ophthalmologist | $200 to $500+ (varies) | Days to weeks (varies) | Ophthalmologist MD or DO | Active eye disease, glaucoma management, history of macular edema or uveitis, or post-surgical evaluation |
| Primary Care | $100 to $250+ (varies) | 3 to 14 days typical | Family medicine or internal medicine MD or DO | Eyelash loss associated with thyroid disease, autoimmune conditions, or medication side effects needing workup |
| Medical Spa | $100 to $300+ per visit (varies) | Days to weeks (varies) | Varies (may include non-physicians) | Cosmetic eyelash services including extensions and lifts, though these do not treat underlying hypotrichosis |
Bottom line: TeleDirectMD is a strong fit for adults seeking an FDA-approved eyelash growth prescription with MD evaluation, safety screening, and detailed application guidance.
Should I Use TeleDirectMD for Eyelash Growth Treatment in Illinois? Decision Guide
Do you have any emergency or red-flag symptoms?
- Sudden vision loss or significant vision changes
- Severe eye pain or eye trauma
- Severe eye infection with swelling, discharge, and fever
- Rapid or patchy eyelash loss with skin changes or scalp hair loss
- Severe allergic reaction with facial swelling or difficulty breathing
If yes, seek urgent in-person care or the ER now
If no, continue to Step 2
Are you 18+ and currently in Illinois?
If yes, continue to Step 3
If no, use in-person care as appropriate
Do you have thin, sparse, or inadequate eyelashes without active eye disease?
- You want longer, thicker, or darker eyelashes
- You do not have active eye infection, inflammation, or pain
- You do not have a history of macular edema or uveitis
- You have not had eye surgery in the past 3 months
If yes, continue to Step 4
If no or you have active eye disease, seek in-person ophthalmology evaluation
You are likely appropriate for a TeleDirectMD video visit
TeleDirectMD can evaluate your eyelash concerns, screen for underlying causes and eye disease, discuss the benefits and risks of bimatoprost (Latisse) including iris darkening and periorbital fat atrophy, and prescribe FDA-approved treatment when clinically appropriate. If your history suggests an underlying condition or active eye disease, we will direct you to the right level of in-person care.
What Does Eyelash Growth Treatment Cost in Illinois?
Transparent options. Insurance is not required.
TeleDirectMD Video Visit
$49
Self pay option. Insurance is not required.
- MD evaluation and red-flag screening for eye disease
- Assessment of eyelash hypotrichosis and underlying causes
- Bimatoprost (Latisse) prescription when clinically appropriate
- Detailed application technique and safety counseling
- Clear follow-up guidance and monitoring plan
Typical Cost Comparison
Common ranges people see before insurance. Actual costs vary.
Prescription costs at your pharmacy are separate and vary by medication and pharmacy. Brand-name Latisse is typically more expensive than generic bimatoprost.
No hidden fees. If medication is not clinically appropriate, you still receive a complete evaluation, guidance, and clear instructions on what level of care you need next.
What Is Eyelash Hypotrichosis?
Eyelash hypotrichosis is a condition characterized by having inadequate or insufficient eyelashes in terms of length, thickness, or darkness. It can result from natural aging, genetic factors, hormonal changes, chemotherapy or radiation therapy, certain skin conditions such as blepharitis or dermatitis, autoimmune conditions such as alopecia areata, thyroid disorders, habitual eyelash pulling (trichotillomania), or chronic use of eyelash extensions or cosmetics that damage the follicles.
Bimatoprost ophthalmic solution 0.03%, marketed as Latisse, is the only FDA-approved prescription treatment for eyelash hypotrichosis. It is a prostaglandin analog originally developed for glaucoma treatment, where increased eyelash growth was consistently observed as a side effect. Bimatoprost extends the anagen (growth) phase of the eyelash hair cycle, resulting in measurably longer, thicker, and darker lashes with consistent use over 8 to 16 weeks.
TeleDirectMD focuses on straightforward eyelash hypotrichosis appropriate for telehealth, with careful screening to direct active eye disease, medically complex eyelash loss, and conditions requiring in-person examination to ophthalmology or dermatology care.
Causes and Risk Factors
Eyelash hypotrichosis has multiple potential causes ranging from natural aging to medical conditions. Understanding the underlying cause helps determine whether telehealth treatment with bimatoprost is appropriate or whether in-person evaluation is needed to address a contributing condition.
- Age-related thinning: eyelashes naturally become thinner, shorter, and lighter with age as the growth cycle slows
- Chemotherapy or radiation: cancer treatments commonly cause temporary or sometimes prolonged eyelash loss, and bimatoprost may help regrowth after treatment completion
- Alopecia areata: autoimmune hair loss can affect eyelashes specifically, though this may require in-person evaluation and treatment beyond bimatoprost alone
- Thyroid disorders: both hypothyroidism and hyperthyroidism can cause eyelash thinning, and the underlying thyroid condition should be addressed
- Blepharitis and chronic eyelid inflammation: ongoing eyelid inflammation can damage lash follicles and may need to be treated before or alongside bimatoprost
- Cosmetic damage: chronic use of eyelash extensions, harsh adhesive removers, eyelash curlers, and waterproof mascara can weaken and break eyelashes over time
Not every case of thin eyelashes is simple hypotrichosis. Sudden or patchy eyelash loss, eyelash loss with scalp hair loss, eyelid lesions, or eyelash loss with eye inflammation may signal an underlying condition that needs in-person evaluation. TeleDirectMD screens for these red flags before prescribing bimatoprost.
Symptoms and Red Flags for Eyelash Growth Treatment in Illinois
Use this table to understand which presentations are appropriate for telehealth bimatoprost prescribing and which require in-person evaluation.
| Symptom or situation | What it suggests | Telehealth appropriate? | Red flag requiring urgent in-person care |
|---|---|---|---|
| Gradually thinning, short, or sparse eyelashes without other symptoms | Age-related or idiopathic eyelash hypotrichosis | Often yes | None, unless accompanied by eye disease or systemic symptoms |
| Eyelash thinning after chemotherapy or radiation has been completed | Treatment-related eyelash loss during recovery | Often yes | If active cancer treatment is ongoing, coordinate with oncology team |
| Eyelash damage from cosmetic products or extensions | Mechanical or chemical follicle damage | Often yes | If eyelid skin changes, infection, or allergic reaction present |
| Eyelash thinning with dry eyes, fatigue, weight changes | Possible thyroid disorder contributing to hair loss | Sometimes | Needs thyroid evaluation and blood work before cosmetic treatment |
| Patchy eyelash loss with or without scalp hair loss | Possible alopecia areata or other autoimmune condition | Sometimes | In-person dermatology evaluation recommended for diagnosis |
| Eye redness, pain, discharge, or eyelid swelling | Active eye infection or inflammation | No for bimatoprost | Must treat underlying condition before starting bimatoprost |
| Sudden vision changes, severe eye pain, or eyelid mass | Serious eye or orbital pathology | No | Urgent ophthalmology evaluation |
Differential Diagnosis: Eyelash Hypotrichosis vs Other Conditions
Several conditions can cause or mimic eyelash thinning. Distinguishing simple hypotrichosis from medically significant eyelash loss ensures appropriate treatment. TeleDirectMD screens for underlying causes before prescribing bimatoprost to ensure patients receive the right level of care.
Sometimes Appropriate for Telehealth
- Age-related eyelash thinning without active eye disease
- Post-chemotherapy eyelash regrowth support after treatment completion
- Cosmetic eyelash thinning from product damage or overuse of extensions
- Mild idiopathic eyelash hypotrichosis in otherwise healthy adults
- Bimatoprost prescription and safety counseling
Often Requires In-Person Evaluation
- Active blepharitis or meibomian gland dysfunction needing treatment before bimatoprost
- Suspected alopecia areata affecting eyelashes needing dermatologic evaluation
- Thyroid-related hair loss needing blood work and endocrine management
- Trichotillomania (habitual eyelash pulling) needing behavioral health referral
- Eyelid lesions, masses, or suspicious skin changes needing biopsy
Eyelash Hypotrichosis vs Alopecia Areata
Simple eyelash hypotrichosis presents as gradual, bilateral thinning of eyelashes without scalp hair loss or other body hair changes. Alopecia areata typically causes patchy, well-defined areas of hair loss and may affect eyelashes, eyebrows, and scalp simultaneously. Alopecia areata may respond to bimatoprost but often requires in-person evaluation and additional treatments such as corticosteroid injections.
Eyelash Thinning vs Blepharitis
Eyelash thinning from hypotrichosis occurs without significant eyelid inflammation or irritation. Blepharitis causes chronic eyelid inflammation with crusting at the lash base, redness, burning, and can lead to eyelash loss (madarosis). Blepharitis should be controlled before starting bimatoprost to avoid worsening eye irritation.
Bimatoprost Side Effects vs New Eye Disease
Bimatoprost commonly causes mild conjunctival redness and eyelid skin darkening that are expected side effects. New-onset eye pain, significant vision changes, severe redness with discharge, or progressive periorbital hollowing suggest either a bimatoprost complication requiring reassessment or a new eye condition needing in-person ophthalmology evaluation.
If your eyelash loss has features suggesting an underlying medical condition or if you develop concerning symptoms after starting bimatoprost, TeleDirectMD will direct you to in-person ophthalmology, dermatology, or endocrinology care as appropriate.
When Is a Video Visit Appropriate?
When a Video Visit Is Appropriate
- Gradual eyelash thinning or sparse lashes without active eye disease
- Interest in FDA-approved bimatoprost (Latisse) for eyelash growth
- No active eye infection, inflammation, or pain
- No history of macular edema or uveitis
- No recent eye surgery within the past 3 months
- Located in Illinois at time of visit
Red Flags Requiring In-Person or ER Care
- Sudden vision loss or significant vision changes
- Severe eye pain or eye trauma
- Active eye infection with swelling, discharge, and redness
- Eyelid mass, lesion, or suspicious skin changes
- Sudden or patchy eyelash loss with scalp hair loss suggesting systemic disease
- Progressive periorbital hollowing or significant iris color change while on bimatoprost
If any red-flag symptoms are present, seek urgent in-person or emergency care. TeleDirectMD is not appropriate for these situations.
Treatment Options
Bimatoprost ophthalmic solution 0.03% (Latisse) is the only FDA-approved prescription treatment for eyelash hypotrichosis. It is a prostaglandin analog that extends the growth phase of the eyelash hair cycle. Noticeable results typically begin at 8 weeks, with full results at 16 weeks. Treatment must be continued to maintain results, as eyelashes gradually return to their pre-treatment state over weeks to months after discontinuation.
Bimatoprost (Latisse) — only FDA-approved treatment
Bimatoprost 0.03% is applied once daily at bedtime to the upper eyelash line only using a sterile applicator, one per eye per application. It must not be applied to the lower lashes or directly into the eye. Contact lenses must be removed before application and should not be reinserted for at least 15 minutes. Excess solution should be blotted from the skin to prevent unwanted hair growth on adjacent areas.
Important safety risks
Bimatoprost may cause iris darkening (increased brown pigmentation) that is likely permanent, particularly in patients with hazel, green, or mixed-color irides. Periorbital fat atrophy, which causes hollowing around the eyes, is a recognized risk that may not fully reverse after discontinuation and patients should be counseled to discontinue and seek evaluation if they notice deepening of the upper eyelid sulcus. Eyelid skin darkening is usually reversible after stopping treatment. Conjunctival hyperemia (eye redness) and mild itching are common.
Over-the-counter lash serums
Many cosmetic eyelash serums contain peptides, biotin, or prostaglandin analogs at lower concentrations than prescription bimatoprost. These products are not FDA-approved for eyelash growth, have limited clinical evidence, and results vary significantly. Some may cause similar side effects to bimatoprost. Patients who have not seen results with OTC products may benefit from prescription-strength bimatoprost.
Supportive care and lash health
Regardless of bimatoprost use, gentle eyelid hygiene, avoiding mechanical trauma from eyelash curlers and harsh makeup removers, limiting eyelash extension use, and treating underlying blepharitis or eyelid inflammation can help maintain eyelash health and support treatment results.
What TeleDirectMD Does Not Manage
- Active eye infections or uveitis needing ophthalmology treatment
- Eyelash loss from uncontrolled alopecia areata needing dermatology care
- Eyelid masses or suspicious lesions needing biopsy
- Glaucoma management or intraocular pressure monitoring
Common Medication Options
Bimatoprost is the primary prescription option for eyelash hypotrichosis. The actual prescription decision is made by the MD after reviewing your medical history, eye health, current medications, and risk factors.
| Medication | Typical dose | Duration | Key considerations |
|---|---|---|---|
| Bimatoprost 0.03% solution (Latisse) | 1 drop on sterile applicator per eye, applied to upper lash line once daily at bedtime | Ongoing (must continue to maintain results) | Only FDA-approved treatment for eyelash hypotrichosis. Results begin at 8 weeks, full results at 16 weeks. Must continue use or lashes return to baseline. Apply ONLY to upper lash line, not lower lashes, not into eye. |
| Generic bimatoprost 0.03% | Same as brand Latisse | Ongoing | Same active ingredient at lower cost. FDA-approved generic available. Same safety profile and application technique as brand-name Latisse. |
| Artificial tears (supportive) | As needed | As needed | For mild eye dryness or irritation that may occur with bimatoprost use. Preservative-free options preferred if using frequently. |
| Eyelid hygiene products (supportive) | Daily | Ongoing | Warm compresses and gentle lid scrubs can help manage blepharitis and support lash health alongside bimatoprost treatment. |
| OTC lash serums (cosmetic) | Per product instructions | Varies | Not FDA-approved for eyelash growth. Limited clinical evidence. May contain peptides, biotin, or low-dose prostaglandin analogs. Prescription bimatoprost has stronger evidence. |
Important: The actual medication decision is made by the MD after reviewing your eye health, medical history, current medications including glaucoma drops, pregnancy status, and risk factors. Bimatoprost is not a controlled substance. TeleDirectMD does not prescribe controlled substances.
Home Care, Application Guide, and Follow-up
How to Apply Bimatoprost Correctly
- Apply once daily at bedtime after removing all makeup, washing your face, and removing contact lenses
- Place one drop of bimatoprost on the sterile applicator provided, use one applicator per eye, and draw it along the skin of the upper eyelash line from inner to outer corner
- Apply ONLY to the upper lash line — do NOT apply to the lower lashes and do NOT drop solution directly into your eye
- Blot excess solution away from the eyelid skin immediately to prevent unwanted hair growth on cheeks or adjacent skin
- Wait at least 15 minutes before reinserting contact lenses after application
What to Watch For During Treatment
- Noticeable lash growth typically begins around 8 weeks with full results at 16 weeks — be patient and consistent
- Mild eye redness or itching in the first few weeks is common and usually improves with continued use
- Monitor for iris color changes, especially if you have hazel, green, or mixed-color eyes — iris darkening may be permanent
- Watch for deepening of the upper eyelid area (periorbital fat atrophy) and discontinue if you notice hollowing around the eyes
- New eye pain, significant vision changes, or signs of eye infection require discontinuing bimatoprost and seeking in-person evaluation
Follow-up and Long-term Use
- Bimatoprost must be used continuously to maintain eyelash growth — lashes gradually return to pre-treatment appearance over weeks to months if treatment is stopped
- Follow up if you notice unwanted side effects including iris darkening, eyelid skin darkening, periorbital hollowing, or persistent eye irritation
- If eyelash growth is inadequate after 16 weeks of consistent daily use, reassessment is recommended to consider underlying causes
- Annual eye exams are recommended for all adults and are especially important if you are using bimatoprost long-term
- If you become pregnant or plan to become pregnant, discuss continuing bimatoprost with your prescriber as it has not been studied in pregnancy
When Not to Use TeleDirectMD for Eyelash Growth Treatment in Illinois
TeleDirectMD is designed for straightforward eyelash hypotrichosis in otherwise healthy adults. We are direct about when telehealth is not appropriate.
You Should Not Use TeleDirectMD If
- You are under 18 years old
- You have active eye infection, inflammation, or severe eye redness
- You have eye pain or sudden vision changes
- You have a history of macular edema, uveitis, or uncontrolled glaucoma
- You have had eye surgery within the past 3 months
- You are pregnant or breastfeeding
- You have sudden or patchy eyelash loss with scalp hair loss suggesting a systemic condition
- You have an eyelid mass, lesion, or suspicious skin changes needing biopsy
- You are not physically in Illinois at the time of visit
Alternative Care Options
- Emergency room: sudden vision loss, severe eye pain, eye trauma, or severe allergic reaction with facial swelling or breathing difficulty
- Ophthalmologist: active eye disease, glaucoma concerns, macular edema, uveitis, recent eye surgery, or significant bimatoprost side effects needing evaluation
- Dermatologist: suspected alopecia areata, eyelid skin conditions, suspicious eyelid lesions needing biopsy, or complex hair loss evaluation
- Primary care: eyelash thinning associated with thyroid disease, autoimmune conditions, medication side effects, or nutritional deficiencies needing workup
Eyelash Growth Treatment FAQs for Illinois
Can I get a bimatoprost (Latisse) prescription online in Illinois?
Yes, if you are an adult 18+ located in Illinois and your medical history is appropriate after red-flag screening. TeleDirectMD can prescribe bimatoprost ophthalmic solution 0.03% (Latisse or generic) when clinically appropriate for eyelash hypotrichosis.
How much does online eyelash growth treatment cost in Illinois?
TeleDirectMD offers a transparent self pay option starting at $49 for an adult video visit in Illinois. Insurance is not required. Prescription costs at your pharmacy are separate and vary, with generic bimatoprost typically costing less than brand-name Latisse.
How long does it take for bimatoprost (Latisse) to work?
Most patients notice initial improvement in eyelash length and thickness around 8 weeks, with full results at 16 weeks of consistent daily use. Results vary between individuals. If no improvement is seen after 16 weeks of proper use, reassessment is recommended.
Will my eyelashes stay long if I stop using bimatoprost?
No. Bimatoprost must be used continuously to maintain results. Once you stop applying it, your eyelashes will gradually return to their pre-treatment length, thickness, and darkness over a period of weeks to months as the normal eyelash growth cycle resumes.
Can bimatoprost change my eye color?
Yes. Bimatoprost may cause increased brown pigmentation of the iris (the colored part of the eye), and this change is likely permanent. This risk is highest in patients with mixed-color irides such as hazel, green-brown, or blue-brown eyes. Patients with fully brown or fully blue eyes have a lower but not zero risk. You should discuss this risk with your prescriber before starting treatment.
What is periorbital fat atrophy and should I worry about it?
Periorbital fat atrophy is a deepening or hollowing of the area around the eyes caused by loss of fat tissue in the orbital area. It has been reported with long-term use of prostaglandin analogs including bimatoprost. The change may not fully reverse after stopping the medication. If you notice a sunken or hollow appearance around your eyes, discontinue bimatoprost and seek evaluation.
Can I apply bimatoprost to my lower lashes?
No. Bimatoprost should be applied only to the skin of the upper eyelash line. Do not apply it to the lower lashes. The solution naturally transfers to the lower lash line through blinking, which provides some benefit. Applying directly to lower lashes increases the risk of the solution entering the eye and causing side effects.
Can I wear contact lenses while using bimatoprost?
You must remove contact lenses before applying bimatoprost and wait at least 15 minutes before reinserting them. Bimatoprost contains benzalkonium chloride, a preservative that can be absorbed by soft contact lenses and may cause eye irritation.
Is bimatoprost (Latisse) the same as a glaucoma medication?
Bimatoprost was originally developed as a glaucoma medication (Lumigan) to lower intraocular pressure. Latisse uses the same active ingredient at the same concentration but is applied to the eyelash line rather than instilled into the eye. If you are already using glaucoma eye drops, tell your prescriber, as combining prostaglandin analogs may have additive effects on intraocular pressure.
Does TeleDirectMD treat eyelash growth in other states?
Yes. TeleDirectMD offers adult evaluations via video visits across multiple states where our physicians are licensed. You must be physically located in the state where you are requesting care at the time of your video visit.
Can TeleDirectMD treat teenagers or children for eyelash growth?
No. TeleDirectMD treats adults 18+ only. Bimatoprost has not been established as safe and effective in patients under 18. Adolescents with eyelash concerns should be evaluated by a pediatric dermatologist or ophthalmologist.
Can I use my insurance for a TeleDirectMD visit?
Insurance is not required. If your plan is eligible, you may be able to use insurance. A self pay option is also available. Note that many insurance plans consider eyelash growth treatment cosmetic and may not cover the prescription itself.
Are over-the-counter lash serums as effective as bimatoprost?
Over-the-counter lash serums are not FDA-approved for eyelash growth and have limited clinical evidence compared to bimatoprost. Some contain prostaglandin analogs at lower concentrations or peptides that may provide modest benefits, but results are generally less consistent and less dramatic than prescription bimatoprost. If OTC products have not worked for you, prescription bimatoprost may be more effective.
What if my eyelash loss is from a medical condition?
If your eyelash loss is caused by an underlying condition such as alopecia areata, thyroid disease, or medication side effects, the underlying cause should be evaluated and treated in addition to or before starting bimatoprost. TeleDirectMD screens for red flags suggesting underlying conditions and will refer you to in-person dermatology, endocrinology, or ophthalmology when appropriate.
Need help today?
Insurance is not required. Adult-only video visits. MD-only care. Safety-first screening, FDA-approved eyelash growth prescriptions when appropriate, and clear next steps.
References
- FDA Label for Latisse (Bimatoprost Ophthalmic Solution 0.03%)
- Smith S et al., Bimatoprost for Eyelash Growth: A Review of Safety and Efficacy, Expert Opinion on Drug Safety
- Eyelash Hypotrichosis Treatment Overview, StatPearls (2025)
- Prostaglandin-Associated Periorbitopathy: A Review, Survey of Ophthalmology
- Bimatoprost in the Treatment of Eyelash Universalis in Alopecia Areata, British Journal of Dermatology
TeleDirectMD Telehealth Disclaimer
TeleDirectMD provides MD-only virtual care for adults (18+) in Illinois using secure video visits to evaluate eyelash hypotrichosis, provide evidence-based guidance, and prescribe bimatoprost (Latisse) when clinically appropriate. Insurance is not required. You must be physically located in Illinois at the time of your video visit. TeleDirectMD does not prescribe controlled substances.
TeleDirectMD is not an emergency service and is not a replacement for urgent in-person care during eye emergencies, severe allergic reactions, or acute vision changes. This service is intended for straightforward eyelash hypotrichosis and is not a substitute for comprehensive ophthalmologic or dermatologic evaluation when red flags are present.
Online eyelash growth treatment in Illinois. Bimatoprost prescription online. Latisse prescription by video visit. Eyelash hypotrichosis treatment online in Illinois.
Get Eyelash Growth Treatment Treatment in Other States
TeleDirectMD treats eyelash growth treatment via telehealth in 39 states. If you are traveling, relocating, or helping a family member in another state, select below to find this treatment near them.